David Badesch is a Respiratory physician affiliated with University of Colorado Hospital. OpenAlex indexes 298 publications with 42,665 citations (h-index 79); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12605 E 16th Ave
Aurora, CO 800452545
Telephone
720-848-0000Registry record last updated 7 Oct 2011.
Clinical trials
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202548 payments$42,210openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202434 payments$29,489openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20244 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 1990–2008 per NIH RePORTER. The latest:
- DEPRESSIVE SYMPTOMS IN PULMONARY ARTERIAL HYPERTENSION: PILOT STUDY TO DETERM
University of Colorado Denver
FY2008$2,136M01RR000051 - STDY OF SIROLIMUS/RAPAMYCIN IN PTS W/ADVNCD PAH REFRACTORY TO CRNTLY AVAIL THRPY
University of Colorado Denver
FY2008$277M01RR000051 - DEPRESSIVE SYMPTOMS IN PULMONARY ARTERIAL HYPERTENSION: PILOT STUDY TO DETERM
University of Colorado Denver
FY2007$18,177M01RR000051
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
New England Journal of Medicine
2023 - Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry
Journal of the American Heart Association
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Kristen Nadeau, MD
University of Colorado Hospital
Anne Fuhlbrigge, MD, MS
University of Colorado Hospital
Isaac Teitelbaum, MD
University of Colorado Hospital
Ken Winston, MD
University of Colorado Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”